Showing 361-370 of 2123 results for "".
Novel Lipid-Lowering Agents and Stroke Prevention:
New Tools, New Targetshttps://practicalneurology.com/diseases-diagnoses/stroke/novel-lipid-lowering-agents-and-stroke-preventionbrnew-tools-new-targets/32074/Established and novel lipid-lowering agents offer increasing opportunities to achieve effective primary and secondary stroke prevention.Special Report: Cognitive Screening After COVID-19
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/special-report-cognitive-screening-after-covid-19/31791/Tools are needed for the assessment of neurologic and neuropsychologic sequelae of infection with the SARS-CoV-2 virus.Patient-Reported Outcome Measures in Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/patient-reported-outcome-measures-in-neuromuscular-disorders/35531/Information gleaned from patient-reported outcome measures provides valuable insights into the effects of neuromuscular disorders on function and quality of life.Update on Treatment Options for Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/update-on-treatment-options-for-dementia/30528/Although there is no treatment to correct the pathological process that leads to AD, there is a large window of opportunity to treat this condition before it becomes clinically evident.Cannabinoids and Psychedelics for Headache Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/cannabinoids-and-psychedelics-for-headache-management/32131/Reports of success in self-treatment of primary headache disorders with cannabis and psilocybin have led to clinical trials studying their efficacy and safety.Sphingosine-1-Phosphate Modulators for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/sphingosine-1-phosphate-modulators-for-multiple-sclerosis/31629/Sphingosine-1-phosphate modulators may act through more than just inhibition of neuroimmune and neuroinflammatory effects of multiple sclerosis.Dementia Insights: What Do Animal Models of Alzheimer’s Disease Tell Us?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-what-do-animal-models-ofalzheimers-disease-tell-us/31560/Understanding pathologic mechanisms provides test beds for finding treatments.Normal Pressure Hydrocephalus
https://practicalneurology.com/diseases-diagnoses/child-neurology/normal-pressure-hydrocephalus/30200/A treatable cause of dementia.Unraveling the Impact of Environmental Factors on Sleep Quality and Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/unraveling-the-impact-of-environmental-factors-on-sleep-quality-and-parkinson-disease/32197/A review of the effects of various environmental factors—extreme temperatures, air and noise pollution, chemical exposures, and heavy metals—on both sleep and Parkinson disease.Parkinson Disease Treatment Advances
https://practicalneurology.com/diseases-diagnoses/movement-disorders/parkinson-disease-treatment-advances/31935/New agents, formulations, and procedures to improve Parkinson disease treatment.